An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms, Haematologica, vol.100, issue.9, pp.1117-1147, 2015. ,
DOI : 10.3324/haematol.2014.114660
How we treat lower-risk myelodysplastic syndromes, Blood, vol.121, issue.21, pp.4280-4286, 2013. ,
DOI : 10.1182/blood-2013-02-453068
The genetic basis of myelodysplasia and its clinical relevance, Blood, vol.122, issue.25, pp.4021-4055, 2013. ,
DOI : 10.1182/blood-2013-09-381665
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes, Leukemia, vol.82, issue.2, pp.241-248, 2014. ,
DOI : 10.1038/leu.2013.336
CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia, Journal of Hematology & Oncology, vol.11, issue.11, p.66, 2014. ,
DOI : 10.1186/s13045-014-0066-4
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia, Blood, vol.124, issue.9, pp.1513-1534, 2014. ,
DOI : 10.1182/blood-2014-03-560227
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases, Journal of Hematology & Oncology, vol.116, issue.1, p.45, 2015. ,
DOI : 10.1186/s13045-015-0139-z
Clinical and biological implications of driver mutations in myelodysplastic syndromes, Blood, vol.122, issue.22, pp.3616-3643, 2013. ,
DOI : 10.1182/blood-2013-08-518886
Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations, Journal of Hematology & Oncology, vol.17, issue.1, p.94, 2014. ,
DOI : 10.1186/s13045-014-0094-0
Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts, Journal of Hematology & Oncology, vol.27, issue.1, p.89, 2014. ,
DOI : 10.1186/s13045-014-0089-x
Discovering Transcription and Splicing Networks in Myelodysplastic Syndromes, PLoS ONE, vol.67, issue.11, p.79118, 2013. ,
DOI : 10.1371/journal.pone.0079118.s001
Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities, Blood, vol.104, issue.13, pp.4210-4218, 2004. ,
DOI : 10.1182/blood-2004-01-0103
Identification of gene networks associated with acute myeloid leukemia by comparative molecular methylation and expression profiling, Biomark Cancer, vol.2, pp.43-55, 2010. ,
Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells, Leukemia, vol.29, issue.5, pp.1092-103, 2015. ,
DOI : 10.1016/j.febslet.2013.05.030
Clinical implications of gene expression profiling in myelodysplastic syndromes: Recognition of ribosomal and translational gene dysregulation and development of predictive assays, Best Practice & Research Clinical Haematology, vol.22, issue.2, pp.223-260, 2009. ,
DOI : 10.1016/j.beha.2009.04.006
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes, Nature Communications, vol.2, p.5901, 2015. ,
DOI : 10.1038/ncomms6901
Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow, Blood, vol.100, issue.10, pp.3553-60, 2002. ,
DOI : 10.1182/blood.V100.10.3553
Altered Hematopoietic Cell Gene Expression Precedes Development of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia and Identifies Patients at Risk, Cancer Cell, vol.20, issue.5, pp.591-605, 2011. ,
DOI : 10.1016/j.ccr.2011.09.011
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells, Leukemia, vol.12, issue.4, pp.756-64, 2010. ,
DOI : 10.1007/s00018-009-9153-z
Identification of Gene Expression???Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes, Journal of Clinical Oncology, vol.31, issue.28, pp.313557-64, 2013. ,
DOI : 10.1200/JCO.2012.45.5626
Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression, Blood, vol.114, issue.23, pp.4847-58, 2009. ,
DOI : 10.1182/blood-2009-08-236422
Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling, Blood, vol.123, issue.21, pp.3327-3362, 2014. ,
DOI : 10.1182/blood-2013-07-512855
Gene expression profiling in MDS and AML: potential and future avenues, Leukemia, vol.114, issue.6, pp.909-929, 2011. ,
DOI : 10.1182/blood-2009-01-202606
Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?, Haematologica, vol.98, issue.1, pp.10-22, 2013. ,
DOI : 10.3324/haematol.2012.069385
Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9, Journal of Hematology & Oncology, vol.87, issue.1, p.46, 2015. ,
DOI : 10.1186/s13045-015-0143-3
Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research, Blood, vol.126, issue.9, pp.1057-68, 2015. ,
DOI : 10.1182/blood-2015-01-624239
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia, Nature, vol.102, issue.7290, pp.852-859, 2010. ,
DOI : 10.1038/nature08851
BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells, Blood, vol.122, issue.16, pp.2864-76, 2013. ,
DOI : 10.1182/blood-2012-07-445635
Localization of the NRAS:BCL-2 complex determines anti-apoptotic features associated with progressive disease in myelodysplastic syndromes, Leukemia Research, vol.37, issue.3, pp.312-321, 2013. ,
DOI : 10.1016/j.leukres.2012.10.018
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies, Oncotarget, vol.6, issue.32, pp.32494-508, 2015. ,
BCL-2 and Mutant NRAS Interact Physically and Functionally in a Mouse Model of Progressive Myelodysplasia, Cancer Research, vol.67, issue.24, pp.11657-67, 2007. ,
DOI : 10.1158/0008-5472.CAN-07-0196
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up, Leukemia, vol.12, issue.6, pp.887-92, 1998. ,
DOI : 10.1038/sj.leu.2401044
The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS, Blood, vol.96, issue.12, pp.3932-3940, 2000. ,
Reactive Oxygen Species, DNA Damage, and Error-Prone Repair: A Model for Genomic Instability with Progression in Myeloid Leukemia?, Cancer Research, vol.67, issue.18, pp.8762-71, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-4807
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction, Cell, vol.136, issue.5, pp.823-860, 2009. ,
DOI : 10.1016/j.cell.2009.02.024
Bortezomib is an effective agent for MDS/MPD syndrome with 5q??? anomaly and thrombocytosis, Leukemia Research, vol.31, issue.4, pp.559-62, 2007. ,
DOI : 10.1016/j.leukres.2006.05.018
Reversal of Bortezomib Resistance in Myelodysplastic Syndrome Cells by MAPK Inhibitors, PLoS ONE, vol.25, issue.3, p.90992, 2014. ,
DOI : 10.1371/journal.pone.0090992.g010
Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity, Proceedings of the National Academy of Sciences, vol.110, issue.37, pp.14912-14919, 2013. ,
DOI : 10.1073/pnas.1310894110
5q??? myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics, Oncogene, vol.14, issue.39, pp.3429-3470, 2009. ,
DOI : 10.1038/onc.2009.207
Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients, Leukemia, vol.19, issue.2, pp.230-238, 2006. ,
DOI : 10.1038/sj.leu.2404057
PI3K Class II ?? Controls Spatially Restricted Endosomal PtdIns3P and Rab11 Activation to Promote Primary Cilium Function, Developmental Cell, vol.28, issue.6, pp.647-58, 2014. ,
DOI : 10.1016/j.devcel.2014.01.022
CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma, Blood Cells, Molecules, and Diseases, vol.40, issue.3, pp.401-406, 2008. ,
DOI : 10.1016/j.bcmd.2007.11.005
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q, Blood, vol.118, issue.14, pp.3765-76, 2011. ,
DOI : 10.1182/blood-2011-01-330126
Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia, Cancer, vol.84, issue.7, pp.1596-604, 2008. ,
DOI : 10.1002/cncr.23789
The human RGL (RalGDS-like) gene: cloning, expression analysis and genomic organization, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol.1491, issue.1-3, pp.1-3285, 2000. ,
DOI : 10.1016/S0167-4781(00)00031-2
MUF1/Leucine-Rich Repeat Containing 41 (LRRC41), a Substrate of RhoBTB-Dependent Cullin 3 Ubiquitin Ligase Complexes, Is a Predominantly Nuclear Dimeric Protein, Journal of Molecular Biology, vol.422, issue.5, pp.659-73, 2012. ,
DOI : 10.1016/j.jmb.2012.06.016
Transforming property of TEL-FGFR3 mediated through PI3-K in a T-cell lymphoma that subsequently progressed to AML, Blood, vol.105, issue.5, pp.2115-2138, 2005. ,
DOI : 10.1182/blood-2003-12-4290
Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome, Best Practice & Research Clinical Haematology, vol.17, issue.4, pp.641-51, 2004. ,
DOI : 10.1016/S1521-6926(04)00080-5
A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)., Genes & Development, vol.9, issue.9, pp.1021-1053, 1995. ,
DOI : 10.1101/gad.9.9.1021
Trophinin and tastin, a novel cell adhesion molecule complex with potential involvement in embryo implantation., Genes & Development, vol.9, issue.10, pp.1199-210, 1995. ,
DOI : 10.1101/gad.9.10.1199
SUMOylation in carcinogenesis, Cancer Letters, vol.316, issue.2, pp.113-138, 2012. ,
DOI : 10.1016/j.canlet.2011.10.036
C. elegans AP-2 and Retromer Control Wnt Signaling by Regulating MIG-14/Wntless, Developmental Cell, vol.14, issue.1, pp.132-141, 2008. ,
DOI : 10.1016/j.devcel.2007.12.001
URL : https://hal.archives-ouvertes.fr/in2p3-00115430
Impaired Proliferative Potential of Bone Marrow Mesenchymal Stromal Cells in Patients with Myelodysplastic Syndromes Is Associated with Abnormal WNT Signaling Pathway, Stem Cells and Development, vol.23, issue.14, pp.1568-81, 2014. ,
DOI : 10.1089/scd.2013.0283
Gene expression patterns in myelodyplasia underline the role of apoptosis and differentiation in disease initiation and progression, Transl Oncogenomics, vol.3, pp.137-186, 2008. ,
Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells, Leukemia, vol.130, issue.12, pp.2147-54, 2006. ,
DOI : 10.1038/sj.leu.2404401
Chronic versus acute myelogenous leukemia, Cancer Cell, vol.6, issue.6, pp.531-534, 2004. ,
DOI : 10.1016/j.ccr.2004.12.005
Serine Protease Inhibitor Kunitz-Type 2 Is Downregulated in Myelodysplastic Syndromes and Modulates Cell???Cell Adhesion, Stem Cells and Development, vol.23, issue.10, pp.1109-1129, 2014. ,
DOI : 10.1089/scd.2013.0441
Regulation of Hypoxia-Inducible Factor-1a by Reactive Oxygen Species : New Developments in an Old Debate, Journal of Cellular Biochemistry, vol.72, issue.(4), pp.696-703, 2015. ,
DOI : 10.1002/jcb.25074
Deregulation of the G1/S phase transition in cancer and squamous intraepithelial lesions of the uterine cervix: a case control study, Oncol Rep, vol.20, issue.4, pp.751-60, 2008. ,
Involvement of Cyclin D1 and E2F1 in Intramedullary Apoptosis in Myelodysplastic Syndromes, Journal of Hematotherapy & Stem Cell Research, vol.12, issue.4, pp.443-50, 2003. ,
DOI : 10.1089/152581603322286079
Hypoxia-inducible factor-1?? expression indicates poor prognosis in myelodysplastic syndromes, Leukemia & Lymphoma, vol.72, issue.12, pp.2412-2420, 2012. ,
DOI : 10.1038/sj.leu.2405053
hnRNP F Influences Binding of a 64-Kilodalton Subunit of Cleavage Stimulation Factor to mRNA Precursors in Mouse B Cells, Molecular and Cellular Biology, vol.21, issue.4, pp.1228-1266, 2001. ,
DOI : 10.1128/MCB.21.4.1228-1238.2001
The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts, PLoS ONE, vol.80, issue.4, p.1970, 2008. ,
DOI : 10.1371/journal.pone.0001970.t001
The circadian clock and the hypoxic response pathway in kidney cancer, Tumor Biology, vol.46, issue.4, pp.1-7, 2014. ,
DOI : 10.1007/s13277-013-1076-5
Circadian clock circuitry in colorectal cancer, World Journal of Gastroenterology, vol.20, issue.15, pp.4197-207, 2014. ,
DOI : 10.3748/wjg.v20.i15.4197
Identification of protein-coding and non-coding RNA expression profiles in CD34+and in stromal cells in refractory anemia with ringed sideroblasts, BMC Medical Genomics, vol.18, issue.1, p.30, 2010. ,
DOI : 10.1097/MOL.0b013e3282ef77d1
Treatment-related myelodysplastic syndrome: molecular characteristics and therapy, Current Opinion in Hematology, vol.18, issue.2, pp.77-82, 2011. ,
DOI : 10.1097/MOH.0b013e328343997a
Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody, Haematologica, vol.95, issue.3, pp.415-438, 2010. ,
DOI : 10.3324/haematol.2009.010785
Proteins related to the spindle and checkpoint mitotic emphasize the different pathogenesis of hypoplastic MDS, Leukemia Research, vol.38, issue.2, pp.218-242, 2014. ,
DOI : 10.1016/j.leukres.2013.11.003
Sumoylation and the function of CCAAT enhancer binding protein alpha (C/EBP??), Blood Cells, Molecules, and Diseases, vol.41, issue.1, pp.77-81, 2008. ,
DOI : 10.1016/j.bcmd.2008.02.011
RNA Interference of Interferon Regulatory Factor-1 Gene Expression in THP-1 Cell Line Leads to Toll-Like Receptor-4 Overexpression/Activation As Well As Up-modulation of Annexin-II, Neoplasia, vol.9, issue.12, pp.1012-1032, 2007. ,
DOI : 10.1593/neo.07640
Heat shock proteins in hematopoietic malignancies, Experimental Cell Research, vol.318, issue.15, pp.1946-58, 2012. ,
DOI : 10.1016/j.yexcr.2012.05.012
Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis, Annals of Hematology, vol.64, issue.23, pp.95-101, 2006. ,
DOI : 10.1007/s00277-005-0031-y
Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors, Journal of Clinical Investigation, vol.123, issue.1, pp.315-343, 2013. ,
DOI : 10.1172/JCI64180DS1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533286
The role of renal function loss on circadian misalignment of cytokines EPO, IGF-1, IL-6 and TNF-alfa in chronic renal disease, Neuro Endocrinol Lett, vol.32, issue.2, pp.148-53, 2011. ,
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice, Blood, vol.100, issue.1, pp.238-283, 2002. ,
DOI : 10.1182/blood.V100.1.238
RAG-1-deficient mice have no mature B and T lymphocytes, Cell, vol.68, issue.5, pp.869-77, 1992. ,
DOI : 10.1016/0092-8674(92)90030-G
Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens, Nature Medicine, vol.31, issue.5, pp.566-71, 2009. ,
DOI : 10.1038/nm.1903
FAST DB: a website resource for the study of the expression regulation of human gene products, Nucleic Acids Research, vol.33, issue.13, pp.4276-84, 2005. ,
DOI : 10.1093/nar/gki738
Splicing factor and exon profiling across human tissues, Nucleic Acids Research, vol.38, issue.9, pp.2825-2863, 2010. ,
DOI : 10.1093/nar/gkq008
A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants, BMC Bioinformatics, vol.8, issue.1, p.180, 2007. ,
DOI : 10.1186/1471-2105-8-180
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nature Protocols, vol.99, issue.1, pp.44-57, 2009. ,
DOI : 10.1038/nprot.2008.211
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists, Nucleic Acids Research, vol.37, issue.1, pp.1-13, 2009. ,
DOI : 10.1093/nar/gkn923
PGC-1??-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nature Genetics, vol.34, issue.3, pp.267-73, 2003. ,
DOI : 10.1038/ng1180
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.15545-50, 2005. ,
DOI : 10.1073/pnas.0506580102
International scoring system for evaluating prognosis in myelodysplastic syndromes, Blood, vol.89, issue.6, pp.2079-88, 1997. ,
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes, Blood, vol.114, issue.5, pp.937-51, 2009. ,
DOI : 10.1182/blood-2009-03-209262